Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson’s Disease

Previous studies suggest that the endocannabinoid system plays an important role in the neuropathological basis of Parkinson’s disease (PD). This study was designed to detect potential alterations in the cannabinoid receptors CB1 (CB(1)r) and CB2 (A isoform, CB(2A)r), and in monoacylglycerol lipase...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neurotherapeutics
Autores principales: Navarrete, Francisco, García-Gutiérrez, M. Salud, Aracil-Fernández, Auxiliadora, Lanciego, José L., Manzanares, Jorge
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer International Publishing 2018
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5935636/
https://ncbi.nlm.nih.gov/pubmed/29352424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-018-0603-x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares